MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphomaMichael A. Milhollen, Peter G. Smith, Louis M. Staudt et al.|Blood|2010Cited by 323
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Eric S. Lightcap et al.|Nature Chemical Biology|2017Cited by 228
A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Serge Y. Fuchs et al.|Science Translational Medicine|2021Cited by 139